{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:27:06Z","timestamp":1791350826209,"version":"4.3.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"vor","delay-in-days":381,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion Science","doi-asserted-by":"publisher","award":["JP26460098"],"award-info":[{"award-number":["JP26460098"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion Science","doi-asserted-by":"publisher","award":["JP17K08309"],"award-info":[{"award-number":["JP17K08309"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion Science","doi-asserted-by":"publisher","award":["17J11628"],"award-info":[{"award-number":["17J11628"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion Science","doi-asserted-by":"publisher","award":["S2803"],"award-info":[{"award-number":["S2803"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009268","name":"Alport Syndrome Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000191","name":"Kidney Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000191","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kumamoto University HIGO Program Research Funding"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.chembiol.2018.02.003","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T16:41:52Z","timestamp":1520527312000},"page":"634-643.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["A Split-Luciferase-Based Trimer Formation Assay as a High-throughput Screening Platform for Therapeutics in Alport Syndrome"],"prefix":"10.1016","volume":"25","author":[{"given":"Kohei","family":"Omachi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misato","family":"Kamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Teramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsubasa","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Kaseda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kuwazuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Motomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Shuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ann","family":"Suico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Kai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2018.02.003_bib1","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1681\/ASN.2008101086","article-title":"Cellular origins of type IV collagen networks in developing glomeruli","volume":"20","author":"Abrahamson","year":"2009","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.chembiol.2018.02.003_bib2","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0909825","article-title":"Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation","volume":"363","author":"Accurso","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chembiol.2018.02.003_bib3","doi-asserted-by":"crossref","first-page":"a015438","DOI":"10.1101\/cshperspect.a015438","article-title":"Protein folding and quality control in the ER","volume":"4","author":"Araki","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.chembiol.2018.02.003_bib4","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1126\/science.2349482","article-title":"Identification of mutations in the COL4A5 collagen gene in Alport syndrome","volume":"248","author":"Barker","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2018.02.003_bib5","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1681\/ASN.2009070784","article-title":"Genotype-phenotype correlation in X-linked Alport syndrome","volume":"21","author":"Bekheirnia","year":"2010","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.chembiol.2018.02.003_bib6","doi-asserted-by":"crossref","first-page":"30716","DOI":"10.1074\/jbc.M004569200","article-title":"Type IV collagen of the glomerular basement membrane. Evidence that the chain specificity of network assembly is encoded by the noncollagenous NC1 domains","volume":"275","author":"Boutaud","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2018.02.003_bib7","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/01.ASN.0000046964.15831.16","article-title":"Cyclosporine a slows the progressive renal disease of alport syndrome (X-linked hereditary nephritis): results from a canine model","volume":"14","author":"Chen","year":"2003","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.chembiol.2018.02.003_bib8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4161\/pri.28938","article-title":"The therapeutic potential of chemical chaperones in protein folding diseases","volume":"8","author":"Cortez","year":"2014","journal-title":"Prion"},{"key":"10.1016\/j.chembiol.2018.02.003_bib9","doi-asserted-by":"crossref","first-page":"E1652","DOI":"10.1002\/humu.21312","article-title":"The Alport syndrome COL4A5 variant database","volume":"31","author":"Crockett","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.chembiol.2018.02.003_bib10","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1021\/acschembio.5b00753","article-title":"NanoLuc complementation reporter optimized for accurate measurement of protein interactions in cells","volume":"11","author":"Dixon","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2018.02.003_bib11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1681\/ASN.2014111109","article-title":"Podocyte p53 limits the severity of experimental alport syndrome","volume":"27","author":"Fukuda","year":"2016","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.chembiol.2018.02.003_bib12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev.genom.7.080505.115737","article-title":"Protein misfolding and human disease","volume":"7","author":"Gregersen","year":"2006","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.chembiol.2018.02.003_bib13","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1523-1755.2003.00779.x","article-title":"Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome","volume":"63","author":"Gross","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.chembiol.2018.02.003_bib14","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ki.2011.407","article-title":"Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy","volume":"81","author":"Gross","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.chembiol.2018.02.003_bib15","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0002-9440(10)63883-7","article-title":"Transfer of the alpha 5(IV) collagen chain gene to smooth muscle restores in\u00a0vivo expression of the alpha 6(IV) collagen chain in a canine model of Alport syndrome","volume":"162","author":"Harvey","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.chembiol.2018.02.003_bib16","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/ki.2013.479","article-title":"Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV alpha5 chain","volume":"85","author":"Hashimura","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.chembiol.2018.02.003_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nchembio.275","article-title":"Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis","volume":"6","author":"Hutt","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2018.02.003_bib18","series-title":"Assay Guidance Manual","article-title":"HTS assay validation","author":"Iversen","year":"2004"},{"key":"10.1016\/j.chembiol.2018.02.003_bib19","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/ndt\/12.8.1595","article-title":"Autosomal dominant Alport syndrome linked to the type IV collage alpha 3 and alpha 4 genes (COL4A3 and COL4A4)","volume":"12","author":"Jefferson","year":"1997","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.chembiol.2018.02.003_bib20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/nrc1094","article-title":"Basement membranes: structure, assembly and role in tumour angiogenesis","volume":"3","author":"Kalluri","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.chembiol.2018.02.003_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bbrc.2007.12.037","article-title":"Mutational analysis of type IV collagen alpha5 chain, with respect to heterotrimer formation","volume":"366","author":"Kobayashi","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.chembiol.2018.02.003_bib22","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1046\/j.1523-1755.2003.00323.x","article-title":"Characterization of assembly of recombinant type IV collagen a3, a4, and a5 chains in transfected cell strains","volume":"64","author":"Kobayashi","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.chembiol.2018.02.003_bib23","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00467-009-1433-1","article-title":"Mutant-type 5(IV) collagen in a mild form of Alport syndrome has residual ability to form a heterotrimer","volume":"25","author":"Kobayashi","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.chembiol.2018.02.003_bib24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrneph.2012.259","article-title":"Alport syndrome\u2014insights from basic and clinical research","volume":"9","author":"Kruegel","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.chembiol.2018.02.003_bib25","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/hmg\/3.8.1269","article-title":"Mutations in the type IV collagen alpha 3 (COL4A3) gene in autosomal recessive Alport syndrome","volume":"3","author":"Lemmink","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.chembiol.2018.02.003_bib26","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1681\/ASN.2013030233","article-title":"Global analysis reveals the complexity of the human glomerular extracellular matrix","volume":"25","author":"Lennon","year":"2014","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.chembiol.2018.02.003_bib27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1681\/ASN.2013070798","article-title":"Feasibility of repairing glomerular basement membrane defects in Alport syndrome","volume":"25","author":"Lin","year":"2014","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.chembiol.2018.02.003_bib28","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1038\/ncomms5767","article-title":"Genome dynamics of the human embryonic kidney 293 lineage in response to cell biology manipulations","volume":"5","author":"Lin","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2018.02.003_bib29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.tcb.2010.11.007","article-title":"Chaperoning osteogenesis: new protein-folding disease paradigms","volume":"21","author":"Makareeva","year":"2011","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.chembiol.2018.02.003_bib30","doi-asserted-by":"crossref","first-page":"15912","DOI":"10.1073\/pnas.2536657100","article-title":"Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis","volume":"100","author":"Matsuda","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2018.02.003_bib31","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ki.2014.229","article-title":"The 2014 international workshop on Alport syndrome","volume":"86","author":"Miner","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.chembiol.2018.02.003_bib32","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1073\/pnas.78.5.2879","article-title":"Regulation of collagen synthesis by ascorbic acid","volume":"78","author":"Murad","year":"1981","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2018.02.003_bib33","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1254\/jphs.SC0040081","article-title":"Characterization of the trafficking pathway of cystic fibrosis transmembrane conductance regulator in baby hamster kidney cells","volume":"95","author":"Okiyoneda","year":"2004","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.chembiol.2018.02.003_bib34","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nchembio.1253","article-title":"Mechanism-based corrector combination restores DeltaF508-CFTR folding and function","volume":"9","author":"Okiyoneda","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2018.02.003_bib35","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1203\/00006450-200212000-00004","article-title":"Chemical chaperones: a pharmacological strategy for disorders of protein folding and trafficking","volume":"52","author":"Perlmutter","year":"2002","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.chembiol.2018.02.003_bib36","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1681\/ASN.2012121217","article-title":"Evidence for activation of the unfolded protein response in collagen IV nephropathies","volume":"25","author":"Pieri","year":"2014","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.chembiol.2018.02.003_bib37","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chembiol.2018.02.003_bib38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.matbio.2016.08.006","article-title":"Proteomic definitions of basement membrane composition in health and disease","volume":"57-58","author":"Randles","year":"2017","journal-title":"Matrix Biol."},{"key":"10.1016\/j.chembiol.2018.02.003_bib39","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1016\/S0021-9258(18)53746-7","article-title":"Brefeldin A inhibits degradation as well as production and secretion of collagen in human lung fibroblasts","volume":"268","author":"Ripley","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2018.02.003_bib40","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.molcel.2012.04.015","article-title":"STT3B-dependent posttranslational N-glycosylation as a surveillance system for secretory protein","volume":"47","author":"Sato","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.chembiol.2018.02.003_bib41","doi-asserted-by":"crossref","first-page":"e0161802","DOI":"10.1371\/journal.pone.0161802","article-title":"X-linked and autosomal recessive alport syndrome: pathogenic variant features and further genotype-phenotype correlations","volume":"11","author":"Savige","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.chembiol.2018.02.003_bib42","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.phrs.2016.03.017","article-title":"RAAS inhibition and the course of Alport syndrome","volume":"107","author":"Savva","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.chembiol.2018.02.003_bib43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00467-016-3452-z","article-title":"Prospective study on the potential of RAAS blockade to halt renal disease in Alport syndrome patients with heterozygous mutations","volume":"32","author":"Stock","year":"2017","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.chembiol.2018.02.003_bib44","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.bbrc.2010.12.074","article-title":"Posttranslational negative regulation of glycosylated and non-glycosylated BCRP expression by Derlin-1","volume":"404","author":"Sugiyama","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.chembiol.2018.02.003_bib45","doi-asserted-by":"crossref","first-page":"e01149","DOI":"10.7554\/eLife.01149","article-title":"Nanoscale protein architecture of the kidney glomerular basement membrane","volume":"2","author":"Suleiman","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.chembiol.2018.02.003_bib46","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1038\/srep04258","article-title":"Inhibition of post-translational N-glycosylation by HRD1 that controls the fate of ABCG5\/8 transporter","volume":"4","author":"Suzuki","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chembiol.2018.02.003_bib47","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1073\/pnas.1105787108","article-title":"Correction of the F508del-CFTR protein processing defect in\u00a0vitro by the investigational drug VX-809","volume":"108","author":"Van Goor","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2018.02.003_bib48","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ekir.2017.03.004","article-title":"The chemical chaperone, PBA, reduces ER stress and autophagy and increases collagen IV alpha5 expression in cultured fibroblasts from men with X-linked alport syndrome and missense mutations","volume":"2","author":"Wang","year":"2017","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.chembiol.2018.02.003_bib49","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1172\/JCI71919","article-title":"Chemical chaperone ameliorates pathological protein aggregation in plectin-deficient muscle","volume":"124","author":"Winter","year":"2014","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.chembiol.2018.02.003_bib50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nm.3759","article-title":"Chemical corrector treatment ameliorates increased seizure susceptibility in a mouse model of familial epilepsy","volume":"21","author":"Yokoi","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.chembiol.2018.02.003_bib51","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1172\/JCI58183","article-title":"Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma","volume":"121","author":"Zode","year":"2011","journal-title":"J.\u00a0Clin. Invest."}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945618300436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945618300436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T17:35:00Z","timestamp":1660584900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945618300436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S2451945618300436"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2018.02.003","relation":{},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Split-Luciferase-Based Trimer Formation Assay as a High-throughput Screening Platform for Therapeutics in Alport Syndrome","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2018.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}